Related Experiment Video
Updated: Jun 28, 2026
06:55
Bioengineering Human Microvascular Networks in Immunodeficient Mice
Published on: July 11, 2011
Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds.
Edward I Chang1, Robert G Bonillas, Samyra El-ftesi
1Department of Surgery, Stanford University Medical Center, Stanford, CA 94305, USA.
Summary
This study introduces explanted microcirculatory beds (EMBs) as scaffolds for tissue engineering. Stem cells seeded onto EMBs can integrate and proliferate, offering potential for creating neo-organs and treating organ failure.
Area of Science:
- Regenerative Medicine
- Vascular Biology
- Biomaterials Science
Background:
- Traditional tissue engineering faces challenges with vascularization and host integration.
- Developing functional, implantable engineered tissues requires overcoming these limitations.
Purpose of the Study:
- To present a novel method for tissue engineering using explanted microcirculatory beds (EMBs) as bioscaffolds.
- To assess the viability and integration of various stem cell populations within EMBs.
Main Methods:
- Explanted microcirculatory beds (EMBs) were maintained ex vivo in a bioreactor.
- EMBs were seeded with multipotent adult progenitor cells (MAPCs) and mesenchymal stem cells (MSCs).
- Stem cell behavior, including egress and proliferation, was analyzed within the EMBs.
Main Results:
- MAPCs and MSCs successfully egressed from the EMB vasculature into the parenchymal space.
- Proliferative stem cell clusters formed within the EMBs.
- Transfected MSCs maintained viability and gene expression in vivo.
Conclusions:
- EMBs serve as viable bioscaffolds for stem cell seeding and tissue engineering.
- This approach shows potential for generating neo-organs and for cell-based therapies.
- The technique offers a promising solution for clinical applications in regenerative medicine.
